Abstract
Combined pharmacokinetic and scintigraphic analyses for the comparison of 5-ASA release profiles from MMXTM mesalamine and another delayed-release mesalamine formulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have